Answers are grounded in this paper and cite their sources.
3-Nitro-tyrosine (3-NT), a byproduct of nitrosative stress, is a prominent biomarker for Alzheimer’s Disease (AD). Hence, its quantification is of paramount importance. In the present work, we report the fabrication of a nanocomposite comprised of cationic pillar[5]arene (CPAI)-functionalized AgNPs embedded on the surface of MoS2 microflowers (MoS2@AgNP@CPAI) for the electrochemical detection of 3-NT. The structural stability, crystallinity, and phase purity of the MoS2@AgNP@CPAI nanocomposite were successfully established by comprehensive structural and surface characterizations. The electrochemical performance of the nanocomposite was validated by means of cyclic voltammetry, differential pulse voltammetry, and impedance study. Herein, the host−guest complexation property of pillararenes, together with the electrochemical prowess of MoS2 and AgNPs, was utilized for the detection of 3-NT. This synergism is attributed to a broad linear detection range of 0.5−75 μM and a low detection limit of 0.108 μM, making it ultrasensitive and selective. Furthermore, the robust selectivity of the nanocomposite was observed when multiple interferents, commonly found in the blood stream, were screened. Its practical viability was assessed by the precise quantification of 3-NT in the human blood serum sample with an extraordinary recovery rate of 95.38% to 100.5%, emphasizing that the fabricated nanocomposite demonstrates applicability in diagnosis and AD pathogenesis.
No takes yet. Share an insight, caveat, or question.
Daware et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: